Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

Guardant Health (GH) Other Accumulated Expenses (2023 - 2024)

Guardant Health's Other Accumulated Expenses history spans 2 years, with the latest figure at $68.3 million for Q4 2024.

On a quarterly basis, Other Accumulated Expenses rose 7.67% to $68.3 million in Q4 2024 year-over-year; TTM through Dec 2024 was $68.3 million, a 7.67% increase, with the full-year FY2024 number at $68.3 million, up 7.67% from a year prior.
Other Accumulated Expenses hit $68.3 million in Q4 2024 for Guardant Health, up from $63.5 million in the prior quarter.
Over the last five years, Other Accumulated Expenses for GH hit a ceiling of $68.3 million in Q4 2024 and a floor of $63.5 million in Q4 2023.